- Projects & figures
- News & Events
- Managing your project
- About ERC
On a clear summer night, look up to the sky and what do you see? Ordinary matter such as planets, stars maybe even an asteroid. Millions of little specks, as far as the eyes can reach. This ordinary matter, also known as baryonic matter, is the primary observable component of our universe. But is what we see all that is out there?
CRISPR is a widely used molecular biology tool exploiting an immune process discovered in bacteria. Dr David Bikard studies CRISPR in bacterial cells, in conjunction with different DNA repair systems, to create even newer tools. He hopes to gain insight into bacterial genetics, and develop increasingly effective medical treatments.
If you raise your eyes to the sky, you won't see it but you might sense it passing by. On 12 January just before sunrise in Europe, PicSat, a cube satellite as big as a shoebox and barely as heavy as a brick, will be launched from the Satish Dhawan Space Centre in Sriharikota, India. Supported with a grant from the European Research Council, it is the first nanosatellite to embark on one of the greatest space adventures: exploring, from afar, an exoplanet.
Through her work with the fruit fly Drosophila santomea, Dr Virginie Orgogozo aims to answer one of the most challenging questions of modern evolutionary biology: how do observable characteristics change between species and yet remain stable in a given species?
With her degree in biology, Dr Maria-Elena Torres-Padilla left Mexico and embarked on an international career in epigenetics. She completed her PhD at the Pasteur Institute in Paris and then moved to Cambridge University. In 2006 she joined IGBMC in Strasbourg working as a group leader. She has just been appointed Director of the Institute of Epigenetics and Stem Cells of the Helmholtz Zentrum in Munich. Supported by an ERC grant, she studies the mechanisms controlling embryonic cellular plasticity with the aim of shedding new light on today's fertility issues. In this interview she shares her story as a non-European scientist in Europe.
Dr Málnási-Csizmadia focuses on enzymes, proteins essential for body functions, and the largely unexplored intricate mechanisms underlying their activity. His recent findings could open the way to a ground-breaking development in pharmacology, especially in targeted cancer therapy.
An international research team led by astronomers from the Max Planck Institute for Radio Astronomy (MPIfR, Bonn, Germany) used a collection of large radio and optical telescopes to investigate a newly discovered pulsar, and its white dwarf companion. The observations revealed a system with unusual properties, which weighs twice as much as the Sun, making it the most massive neutron star to date. These findings partly result from the “BEACON” project led by ERC Starting grantee Dr Paulo Freire, and agree with Einstein’s theory on general relativity. They will be published in tomorrow’s issue of Science, April 26, 2013.
Conducting research in small RNAs, Dr. Ramesh Pillai attempts to understand how the genome protects itself from an internal threat, namely ‘transposons’ or ‘jumping genes’ which can cause mutations. Awarded an ERC Starting grant in 2010, Dr. Pillai is based at the European Molecular Biological Laboratory, Grenoble (France).
Quantum theory, despite being one of the most successful scientific theories in history, throws up some bizarre ideas: quantum spin, the uncertainty principle, wave/particle duality, quantum entanglement and non-locality - or “spooky action at a distance” as Einstein once called it. But these are not just abstract concepts or the preserve of theory: Dr Szabolcs Csonka is working on isolating fundamental particles so as to study these phenomena first hand in electrons and thus bring quantum computers one step closer to reality.
The answer to why some people age earlier than others, or why they develop cancer, could lie at the very end sections of our DNA: the telomeres.